Structure-Based Design: Potent Inhibitors of Human Brain Memapsin 2 (β-Secretase)
- 1 August 2001
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (18) , 2865-2868
- https://doi.org/10.1021/jm0101803
Abstract
Read the full review for this F1000Prime recommended article: Structure-based design: potent inhibitors of human brain memapsin 2 (beta-secretase).Keywords
This publication has 12 references indexed in Scilit:
- Structure of the Protease Domain of Memapsin 2 (β-Secretase) Complexed with InhibitorScience, 2000
- Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor proteinProceedings of the National Academy of Sciences, 2000
- β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACEScience, 1999
- Translating cell biology into therapeutic advances in Alzheimer's diseaseNature, 1999
- Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activityNature, 1999
- Adverse effects of reverse transcriptase inhibitorsAIDS, 1998
- HIV-Protease InhibitorsNew England Journal of Medicine, 1998
- Indinavir in cerebrospinal fluid of HIV-1-infected patientsThe Lancet, 1997
- An efficient synthesis of hydroxyethylene dipeptide isosteres: the core unit of potent HIV-1 protease inhibitorsThe Journal of Organic Chemistry, 1991
- Iodination of aryltrimethylsilanes. A mild approach to (iodophenyl)alanineThe Journal of Organic Chemistry, 1986